Name
Session II: Therapeutic Alterations in Immune Cell Composition
Date & Time
Thursday, April 30, 2026, 10:35 AM - 12:05 PM
Speakers
Christopher Jewell, PhD, University of Maryland
James Kochenderfer, MD, National Cancer Institute, National Institutes of Health
Megan Levings, PhD, University of British Columbia
James Kochenderfer, MD, National Cancer Institute, National Institutes of Health
Megan Levings, PhD, University of British Columbia
Description
10:35 AM
Targeting Lymphocytes With CAR T Cells to Treat Autoimmunity
James N. Kochenderfer, MD, National Cancer Institute, National Institutes of Health
11:05 AM
Strategies to Decrease CAR-T Cell Toxicity
Christopher M. Jewell, PhD, University of Maryland
11:35 PM
Strategies to Promote Regulatory T Cell Function in Autoimmunity
Megan K. Levings, PhD, University of British Columbia